Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05446805 · ClinicalTrials.gov registry record
Depression and Driving
A clinical trial of Depression and Drive, sponsored by Ganesh Babulal.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05446805 is a study of Depression and Drive that is actively recruiting participants, run by Ganesh Babulal. The registered enrollment target is 150 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05446805, a study of Depression and Drive, is actively recruiting participants, sponsored by Ganesh Babulal.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will assess how depression, preclinical AD, and antidepressants affect driving behavior in cognitively normal older adults (65 years).
Conditions Studied
Interventions
- DRUG F 18 AV-1451 (Flortaucipir)
- DRUG [11C]-Pittsburgh Compound B ([11C]PiB)
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-06-17 |
| Est. Completion | 2026-12-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05446805
The ClinicalTrials.gov registry entry for NCT05446805 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The listed sponsor is Ganesh Babulal, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which F 18 AV-1451 (Flortaucipir) is the first listed.
NCT05446805 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05446805 about?
NCT05446805 is a clinical study titled "Depression and Driving". This project will assess how depression, preclinical AD, and antidepressants affect driving behavior in cognitively normal older adults (65 years).
What is the current status of trial NCT05446805?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-06-17. Estimated completion is 2026-12-17.
What conditions does trial NCT05446805 study?
This clinical trial studies the following conditions: Depression, Drive.
What interventions are being tested in trial NCT05446805?
The interventions under investigation include: F 18 AV-1451 (Flortaucipir) (DRUG), [11C]-Pittsburgh Compound B ([11C]PiB) (DRUG).
Who is sponsoring clinical trial NCT05446805?
This trial is sponsored by Ganesh Babulal, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05446805 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
-
Dopaminergic Therapy for Anhedonia - 2
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.